Mumbai, Baltimore, August 25, 2020: Pharma major Lupin Limited (Lupin) announced today that it has received approval from the United States Food and D...
Mumbai, Baltimore, August 11, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Zileuton Extended-Release Tablets, 600 mg, having recei...
Mumbai, India, August 05, 2020: Pharma major Lupin Limited (Lupin) today announced the launch of its Favipiravir in India under the brand name Covihal...
The Patient Experience Innovation Summit will be held on the 13th of July 2020, as a virtual webinar, giving attendees an opportunity to stay in touch...
With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. Drug fir...
GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multi...
Mumbai, Baltimore, June 02, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg and 10 m...
Alembic Pharmaceuticals Limited (Alembic) announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated Ne...
AIRZ-FF is India’s first Glycopyrronium + Formoterol + Fluticasone combination, exclusively studied in the Indian population Backed b...
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") announced that it has received final approval for its Abbreviated N...
Dupixent demonstrated significant clinical and anatomic improvements, including the ability to swallow, in Part A of the pivotal trial ...
Dr. Reddy’s Laboratories Ltd., announced the launch of FXR™, a therapeutic equivalent generic version of Ocaliva® (obeticholic acid) in Indi...
